Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.

In the discovery cohort (n = 161), late-metastatic RCC (late-mRCC) was associated with clear cell histology (88.9% vs 78.7%), lower ... phenotypic features with RCC that metastasizes to the pancreas, ...

The database includes a large cohort of patients with pancreatic ductal adenocarcinoma and biliary ... Currently, information about histology, stage of disease at diagnosis or treatment received is ...

Histological analysis confirmed the progression of pancreatic recovery in all treatment groups ... Tissues were fixed with 4% PFA for histology study. The content of biomarkers in serum and urine ...

A 34-year-old woman was found to have a primary NEN of the brain, and she had recurrence with identical histology 10 years later ... thyroid transcription factor-1 (TTF1), CDX2 and a pancreatic ...

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...

People live without their pancreas by taking medications and making good lifestyle choices. Learn about treatments and ...

Van Andel Institute scientists and collaborators have developed a new method for identifying and classifying pancreatic ...

Van Andel Institute scientists and collaborators have developed a new method for identifying and classifying pancreatic ...

Journal of the National Comprehensive Cancer Network found significant disparities based on race, socioeconomic status, and ...

Pancreatic cancer arises from mutations in the DNA of pancreatic cells, leading to uncontrolled growth and tumour formation. While the exact causes are not fully understood, several risk factors ...